Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term melanoma. Found 25 abstracts

no pagination
Perez-Guijarro E, Day CP, Merlino G, Zaidi MR. Genetically engineered mouse models of melanoma. Cancer. 2017 Jun;123(S11):2089-103.   PMCID: PMC5445933
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RH, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 07;170(6):1109-1119e10.
van Tuyn J, Jaber-Hijazi F, MacKenzie D, Cole JJ, Mann E, Pawlikowski JS, Singh Rai T, Nelson DM, McBryan T, Ivanov A, Blyth K, Wu H, Milling S, Adams PD. Oncogene-Expressing Senescent Melanocytes Upregulate Mhc Class Ii, A Candidate Melanoma Suppressor Function. The Journal of investigative dermatology. 2017 Jun 21;137(10):2197-207.   PMCID: PMC5613751
Hooper R, Zaidi MR, Soboloff J. The heterogeneity of store-operated calcium entry in melanoma. Science China Life sciences. 2016 Aug;59(8):764-9.   PMCID: PMC4991353
Ito T, Melamed J, Perle MA, Alukal J. Clear cell sarcoma of the penis: a case report. Am J Clin Exp Urol. 2015 Jan;3(1):43-7.   PMCID: PMC4446382
Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, Plastaras J, Bucci MK, Yock TI, Bonilla L, Price R, Harris EE, Konski AA, Stinseymour M. An evidence based review of proton beam therapy: The report of ASTRO's emerging technology committee. Radiotherapy and Oncology. 2012 Apr;103(1):8-11.   PMCID: not NIH funded
Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE. Mucosal Melanoma of the Head and Neck. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):320-38.   PMCID: not NIH Funded
Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomaki K, Amiano P, Apicella C, Baglietto L, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Brauch H, Brinton L, Bui QM, Buring JE, Buys SS, Campa D, Carpenter JE, Chasman DI, Chang-Claude J, Chen C, Clavel-Chapelon F, Cox A, Cross SS, Czene K, Deming SL, Diasio RB, Diver WR, Dunning AM, Durcan L, Ekici AB, Fasching PA, Feigelson HS, Fejerman L, Figueroa JD, Fletcher O, Flesch-Janys D, Gaudet MM, Gerty SM, Rodriguez-Gil JL, Giles GG, van Gils CH, Godwin AK, Graham N, Greco D, Hall P, Hankinson SE, Hartmann A, Hein R, Heinz J, Hoover RN, Hopper JL, Hu JJ, Huntsman S, Ingles SA, Irwanto A, Isaacs C, Jacobs KB, John EM, Justenhoven C, Kaaks R, Kolonel LN, Coetzee GA, Lathrop M, Marchand L, Lee AM, Lee IM, Lesnick T, Lichtner P, Liu JJ, Lund E, Makalic E, Martin NG, McLean CA, Meijers-Heijboer H, Meindl A, Miron P, Monroe KR, Montgomery GW, Muller-Myhsok B, Nickels S, Nyante SJ, Olswold C, Overvad K, Palli D, Park DJ, Palmer JR, Pathak H, Peto J, Pharoah P, Rahman N, Rivadeneira F, Schmidt DF, Schmutzler RK, Slager S, Southey MC, Stevens KN, Sinn HP, Press MF, Ross E, Riboli E, Ridker PM, Schumacher FR, Severi G, Silva ID, Stone J, Sund M, Tapper WJ, Thun MJ, Travis RC, Turnbull C, Uitterlinden AG, Waisfisz Q, Wang XS, Wang ZM, Weaver J, Schulz-Wendtland R, Wilkens LR, Van Den Berg D, Zheng W, Ziegler RG, Ziv E, Nevanlinna H, Easton DF, Hunter DJ, Henderson BE, Chanock SJ, Garcia-Closas M, Kraft P, Haiman CA, Vachon CM. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human molecular genetics. 2012 Dec;21(24):5373-84.   PMCID: PMC 3510753
Coups EJ, Geller AC, Weinstock MA, Heckman CJ, Manne SL. Prevalence and Correlates of Skin Cancer Screening among Middle-aged and Older White Adults in the United States. American Journal of Medicine. 2010 May;123(5):439-45.   PMCID: PMCID: PMC2858071 [Available on 2011/5/1]
Dominguez-Brauer C, Brauer PM, Chen YJ, Pimkina J, Raychaudhuri P. Tumor suppression by ARF Gatekeeper and caretaker. Cell cycle (Georgetown, Tex). 2010 Jan;9(1):86-9.   PMCID: *
Hay J, Coups EJ, Ford J, DiBonaventura M. Exposure to mass media health information, skin cancer beliefs, and sun protection behaviors in a United States probability sample. Journal of the American Academy of Dermatology. 2009 Nov;61(5):783-92.   PMCID: PMC2854488
Palamar M, Thangappan A, Shields CL, Ehya H, Shields JA. Necrotic Choroidal Melanoma With Scleritis and Choroidal Effusion. Cornea. 2009 Apr;28(3):354-6.   PMCID: not NIH funded
Kucher C, Zhang PJ, Pasha T, Elenitsas R, Wu H, Ming ME, Elder DE, Xu XW. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic Nevi. American Journal of Dermatopathology. 2004 Dec;26(6):452-7.
Gude RP, Binda MM, Presas HL, Klein-Szanto AJ, Bonfil RD. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline. Journal of Biomedical Science. 1999 Mar;6(2):133-41.
Alpaugh RK, von Mehren M, Palazzo I, Atkins MB, Sparano JA, Schuchter L, Weiner LM, Dutcher JP. Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon. Medical Oncology. 1998 Sep;15(3):191-8.
Gunduz K, Shields JA, Shields CL, Eagle RC, Ehya H, McLaughlin W. Lung carcinoma metastatic to the vitreous cavity. Retina-the Journal of Retinal and Vitreous Diseases. 1998 Jan;18(3):285-6.
Bell DW, Jhanwar SC, Testa JR. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Research. 1997 Sep 15;57(18):4057-62.
Padmore RF, Lara JF, Ackerman DJ, Gales T, Sigurdson ER, Ehya H, Cooper HS, Patchefsky AS. Combined malignant melanoma and ductal carcinoma of the breast - A report of two cases. Cancer. 1996 Dec 15;78(12):2515-25.
Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ, Testa JR. P16 Alterations and Deletion Mapping of 9p21-P22 in Malignant Mesothelioma. Cancer Research. 1994 Nov;54(21):5547-51.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term melanoma

melanoma cancer tumor expression malignant-melanoma radiation-therapy Melanoma metastases metastatic melanoma abnormalities tumors chemotherapy metastasis pathology adjuvant therapy neoplasms radiation therapy risk NCCN Clinical Practice Guidelines biopsy NCCN Guidelines interferon p53 genetic instability lymph-node biopsy R24 Ciita cytotoxicity irradiation oncolytic immunotherapy gd3 dna-repair in-vivo alpha-IFN scleritis s100 protein necrosis surgical excision melan-a cytokeratin eye senescence kit mutation society phase-iii Combined Modality Therapy anti-PD-1 colony-stimulating factor combination breast-cancer deletions long arm human tyrosinase Oncolytic Virotherapy adverse effects lymph node dissection task-force pembrolizumab papillary 1987 arlson me-journal of chronic diseases-v40-p373 Tumor Microenvironment tumor-suppressor gene photon homozygous deletions colorectal-cancer effusion 9p choroid biomarkers recombinant interleukin-2 therapy breast neoplasms skin cancer beliefs health communication-sun protection behaviors lung-cancer metabolism B16-F10 heterozygosity postoperative radiotherapy brca1 mutation carriers down-regulation ultraviolet (UV) radiation 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 interleukin-2 model carcinogen metastatic patterns skin retina head and neck cancer clear cell ganglioside uv monoclonal-antibody Ki-67 positron-emission-tomography comorbidity index tumor suppressor ARF-E2F4-XPC-DNA repair desmoplastic isolated limb perfusion cancer-cells invitro benign nucleotide excision-repair carcinomas stage-iii melanoma tumor subtypes cell lung-cancer composite tumor genetic-map Biological Models angiogenesis immunoreactivity primary-care physicians antigen presentation therapy genetics Penis sentinel lymph node mouse models oncolytic viruses t-lymphocytes medullary cooperative-oncology-group mammalian-cells primary cutaneous melanoma Endoplasmic Reticulum mucosal melanoma interleukin 1 cutaneous blocking skull base talimogene laherparepvec pentoxifylline sclerotic population cell-adhesion margin proximal 6q internet Screening Melanoma-Skin cancer-Skin examination neck dissection co-morbidity proliferative activity carcinoma Radiation therapy Proton beam therapy-Evidence based guidelines interferon genes MHC class II nevus pigmentation
Last updated on Friday, January 05, 2018